Hester Biosciences

Hester Biosciences FCF per Share

The Free Cash Flow per Share of Hester Biosciences (HESTERBIO.NS) as of Nov 19, 2026 is 49.03 INR. In the previous year, Free Cash Flow per Share was 51.63 INR — a change of -5.04% (lower).

FCF per Share

49.03INR

YoY

-5.04%

Last updated:

Free Cash Flow per Share of Hester Biosciences is 2026 49.03 INR. Free Cash Flow per Share of Hester Biosciences was 2025 51.63 INR. It decreases by -5.04% lower compared to the previous year.

The Hester Biosciences FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2019
30.04 INR
Jan 1, 2020
-41.39 INR
Jan 1, 2021
20.35 INR
Jan 1, 2022
-102.15 INR
Jan 1, 2023
-63.67 INR
Jan 1, 2024
27.29 INR
Jan 1, 2025
51.63 INR
Jan 1, 2026
49.03 INR
The Hester Biosciences FCF per Share history
YEARFCF per ShareYoY
49.03INR-5.04%
51.63INR+89.15%
27.29INR-142.87%
-63.67INR-37.67%
-102.15INR-602.00%
20.35INR-149.17%
-41.39INR-237.75%
30.04INR+69.78%
17.70INR+230.51%
5.35INR-17.88%
6.52INR+45.27%
4.49INR-171.46%
-6.28INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hester Biosciences stock

Free Cash Flow per Share of Hester Biosciences is 49.03 INR in 2026.

Free Cash Flow per Share of Hester Biosciences changed from 51.63 INR to 49.03 INR, representing a -5.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hester Biosciences

All Key Metrics — Hester Biosciences